Sensars is pioneering neuromodulation for diabetic neuropathy with SENSY, the first system to restore natural sensations to the feet, preventing complications like ulcers, amputations, falls, and addressing chronic neuropathic pain. With over25 peer-reviewed publications, successful clinical studies, $3.5M in undiluted grants, and a breakthrough device designation from the FDA, Sensars is advancing its proven technology, moving toward pivotal trials and commercial readiness.
Company Details
- Employees
- 4
- Address
- Lausanne, Vaud 1003, Ch
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- sensars.com
- Keywords
- Dallas.
- HQ
- Lausanne, Vaud
Sensars Questions
Sensars's website is sensars.com
Sensars's LinkedIn profile is https://ch.linkedin.com/company/sensars-sarl
Sensars has
4 employees.
View email and phone details for 4
employees at Sensars.
Sensars's industry is
Medical Equipment Manufacturing
Sensars's top competitors are
Mucolife Therapeutics,
Epios,
Aleva Neurotherapeutics Sa,
Lemur Pbc,
Keyron Medical Technology,
Healthcare Shares,
Rhythmm Ai,
Brainscape Medical,
Neurosoft Bioelectronics,
Firstday Healthcare.
Sensars's categories are Medical Equipment Manufacturing
